Breast milk drug levels measured in healthy moms

NCT ID NCT06720714

First seen Apr 25, 2026 · Last updated Jun 13, 2026 · Updated 10 times

Summary

This study looked at how much of the drug rozanolixizumab gets into the breast milk of healthy women who were already planning to stop breastfeeding. Fifteen women received a single dose, and researchers measured drug levels in their milk over a week. The goal was to understand potential infant exposure, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UP0141 1

    Salt Lake City, Utah, 84124, United States

  • UP0141 2

    San Antonio, Texas, 78209, United States

Conditions

Explore the condition pages connected to this study.